Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Apotex Corp.
Current Parent CompanyApotex Corp.
Parent at the Time of the Penalty Announcement subscribe to see this data field
Penalty: $24,100,000
Year: 2020
Date: May 7, 2020
Offense Group: competition-related offenses
Primary Offense: price-fixing or anti-competitive practices
Violation Description: Apotex Corp., a generic pharmaceutical company headquartered in Florida, agreed to pay a criminal penalty of $24.1 million under a deferred prosecution agreement relating to fixing the price of the generic drug pravastatin.
Level of Government: federal
Action Type: agency action
Agency: Justice Department Antitrust Division
Civil or Criminal Case: criminal
Prosecution Agreement: deferred prosecution agreement
HQ Country of Current Parent: Canada
Ownership Structure of Current Parent: privately held
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: generic drugs
Source of Data(click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.